The aim of this study is to compare the effects of diadynamic current (DDT), interferential current (IFT) and transcutaneous electrical nerve stimulation (TENS) therapies on pain and disability levels in patients with chronic low back pain (CLBP). Patients with chronic low back pain between the ages of 18-65 were included in the study. The patients were divided into 3 groups. The first group received DDT, the second group IFT, and the third group TENS. The patients were evaluated in terms of pain and disability levels before the treatment, at the 0th day after the treatment, and at the 1st month after the treatment. Thus, these three treatment modalities were compared in terms of their effectiveness. A total of 83 patients were included in the study. There was no statistically significant difference between the groups in terms of age, gender, BMI, disease duration, pain, and disability levels of the patients before treatment. A statistically significant difference was found between the 0th day before and after the treatment and the 1st month before and after the treatment in terms of pain and disability levels in all three groups. The VAS scores of the individuals in the IFT group were significantly lower on the 0th day and 1st month after the treatment than in the DDT and TENS groups. Although there was no statistically significant difference, when looked clinically, the RMDQ scores of the individuals in the IFT group tended to decrease more than those in the DDT and TENS groups. All three treatment modalities are effective in patients with CLBP. However, IFC seems to be superior.
Chronic low back pain diadynamic current interferential current transcutaneous electrical nerve stimulation
None
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Clinical Research |
Authors | |
Publication Date | October 29, 2022 |
Submission Date | August 17, 2022 |
Acceptance Date | August 28, 2022 |
Published in Issue | Year 2022 Volume: 39 Issue: 4 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.